Bleichroeder LP’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-269,675
| Closed | -$2.47M | – | 79 |
|
|
2025
Q1 | $2.47M | Hold |
269,675
| – | – | 0.66% | 17 |
|
|
2024
Q4 | $1.8M | Hold |
269,675
| – | – | 0.45% | 23 |
|
|
2024
Q3 | $2.71M | Hold |
269,675
| – | – | 0.73% | 18 |
|
|
2024
Q2 | $4.21M | Hold |
269,675
| – | – | 1.25% | 15 |
|
|
2024
Q1 | $5.91M | Hold |
269,675
| – | – | 1.47% | 15 |
|
|
2023
Q4 | $5.22M | Hold |
269,675
| – | – | 1.16% | 13 |
|
|
2023
Q3 | $4.98M | Hold |
269,675
| – | – | 1.23% | 16 |
|
|
2023
Q2 | $4.98M | Hold |
269,675
| – | – | 1.01% | 20 |
|
|
2023
Q1 | $7.81M | Hold |
269,675
| – | – | 1.67% | 15 |
|
|
2022
Q4 | $7.48M | Buy |
269,675
+17,543
| +7% | +$666K | 1.63% | 16 |
|
|
2022
Q3 | $13.8M | Hold |
252,132
| – | – | 2.89% | 12 |
|
|
2022
Q2 | $13.8M | Buy |
252,132
+2,653
| +1% | +$97.6K | 2.86% | 10 |
|
|
2022
Q1 | $9.24M | Buy |
249,479
+1,466
| +0.6% | +$52.3K | 1.64% | 19 |
|
|
2021
Q4 | $6.03M | Buy |
+248,013
| New | +$8.3M | 0.94% | 23 |
|
Bleichroeder LP's OPTN Position: Q2 2025 in Review
Bleichroeder LP sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 269,675 shares — an estimated $2.47M sold.
Bleichroeder LP first reported a position in OPTN in Q4 2021 and held it in 14 quarters. The position peaked at $13.8M in Q3 2022. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Bleichroeder LP reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Bleichroeder LP sold 269,675 OptiNose shares in Q2 2025, an estimated $2.47M.
- Bleichroeder LP first reported a position in OptiNose in Q4 2021 and held it in 14 quarters.
- Bleichroeder LP's OptiNose position peaked at $13.8M in Q3 2022.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Bleichroeder LP's 13F filing for Q2 2025, filed 14 Aug 2025.